Advisory Resource Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,528
Closed -$202K 161
2024
Q1
$202K Buy
+1,528
New +$188K 0.05% 157
2023
Q4
Sell
-2,809
Closed -$289K 156
2023
Q3
$289K Sell
2,809
-23,600
-89% -$2.54M 0.08% 131
2023
Q2
$3.05M Sell
26,409
-279
-1% -$31.7K 0.83% 31
2023
Q1
$2.84M Buy
26,688
+1,364
+5% +$147K 0.8% 35
2022
Q4
$2.81M Sell
25,324
-2,722
-10% -$278K 0.84% 25
2022
Q3
$2.42M Buy
28,046
+139
+0.5% +$12.4K 0.8% 28
2022
Q2
$2.54M Sell
27,907
-4,407
-14% -$391K 0.83% 23
2022
Q1
$2.65M Buy
32,314
+1,568
+5% +$124K 0.83% 29
2021
Q4
$2.5M Sell
30,746
-55
-0.2% -$4.38K 0.84% 36
2021
Q3
$2.31M Buy
30,801
+272
+0.9% +$20.7K 0.85% 27
2021
Q2
$2.37M Buy
30,529
+5,192
+20% +$386K 0.95% 23
2021
Q1
$1.86M Buy
+25,337
New +$1.87M 0.87% 31

Other funds holding MRK

Advisory Resource Group's MRK Position: Q2 2024 in Review

Advisory Resource Group sold out of Merck (MRK) in Q2 2024, closing a stake of 1,528 shares — an estimated $202K sold.

Advisory Resource Group first reported a position in MRK in Q1 2021 and held it in 12 quarters. The position peaked at $3.05M in Q2 2023. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • Advisory Resource Group reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • Advisory Resource Group sold 1,528 Merck shares in Q2 2024, an estimated $202K.
  • Advisory Resource Group first reported a position in Merck in Q1 2021 and held it in 12 quarters.
  • Advisory Resource Group's Merck position peaked at $3.05M in Q2 2023.
  • 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Advisory Resource Group's 13F filing for Q2 2024, filed 24 Jul 2024.